The Lancet Oncology in conversation with
Professor Amar U. Kishan on HYpofractionateD RAdiotherapy for Prostate Cancer (HYDRA)
Dienstag, 1. April 2025 · 8 min
Kapitelklicken springt direkt hin
Shownotes
Professor Amar U. Kishan (Department of Radiation Oncology, University of California, Los Angeles, CA, USA) discusses his paper on HYpofractionateD RAdiotherapy for Prostate Cancer (HYDRA): An Individual Patient Data Meta-Analysis of Randomised Trials in the MARCAP Consortium.
Read the full article:
thelancet.com/journals/lanonc/article/PIIS1470…)00034-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanonc
Tell us what you thought about this episode (buzzsprout.com/1391338/fan_mail/new)
Continue this conversation on social!
Follow us today at...
facebook.com/thelancetmedicaljournal
linkedIn.com/company/the-lancet (linkedin.com/company/the-lancet)
